Date on which the terms and conditions of the repair issue were announced: 5 May 2016
Last day including right: 25 May 2016
Ex-date: 26 May 2016
Record Date: 27 May 2016
Date of approval: 26 May 2016
Maximum number of new shares: 6,676,440
Subscription price: NOK 2 per share
 
Other information: The board of directors reserves the right to withdraw the suggestion for a subsequent offering if the board of directors considers that the trading in the Company's shares in the period between 22 April 2016 and the date of the annual general meeting has been at a level which have given eligible shareholders the possibility of limiting the effects of the private placement resolved on 22 April 2016 through purchase of shares in the open market.
 
This information is published in accordance with the requirements of the Continuing Obligations.
 
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hofseth Biocare ASA via Globenewswire
HUG#2011674